"

13.2 Undiagnosed BIPOC Populations

 

Table 13.1. Diagnostic distribution by race of patients from the DSM-IV Field Trial for schizophrenia and other psychotic disorders
Diagnosis Black

(n = 86)

(%)

White

(n = 244)

(%)

Total

(n = 330)

(%)

Schizophrenia 52 (60)* 117 (48) 169 (51)
Bipolar disorder 8 (9) 30 (12) 38 (912)
Schizoaffective disorder 10 (12) 26 (11) 36 (11)
Schizophreniform disorder 8 (9) 16 (7) 24 (7)
Major depression 1 (1)b 20 (8) 21 (6)
Delusional disorder 2 (2) 13 (5) 15 (5)
Psychosis NOS 3 (4) 12 (5) 15 (5)
Other 2 (2) 10 (4) 12 (3)
NOS, not-otherwise-specified

*Significant difference versus White; ORa = 1.4, 95% CI – 1.0-1.8; p = 0.03.

bSignificant difference versus White; ORa = 2.8, 95% CI = 1.0 – 7.8; p = 0.04.

African American patients are disproportionately diagnosed with psychotic disorders despite the absence of genetic evidence indicating a true elevation in prevalence in this population. Meta-analytic reviews have shown that, among patients admitted to state psychiatric hospitals, African American patients are almost five times more likely than White patients to be diagnosed with schizophrenia. Latine American patients are also more likely than White patients to be diagnosed with psychotic disorders.

License

Hidden Voices in Gen Psych Copyright © by Joyce Yang; ahitti; Zachary Reese; and lma32. All Rights Reserved.